ADCK1 Activators
ADCK1 activators would constitute a class of chemical compounds specifically designed to upregulate the activity of the protein kinase ADCK1. ADCK1, or aarF domain-containing kinase 1, belongs to a family of atypical protein kinases that share a distinct aarF domain. Unlike conventional protein kinases, ADCK1 and its homologues have been less characterized and are considered to be atypical due to their unique sequence features and structural attributes. The precise biological function of ADCK1 is not well established, but it is hypothesized to play a role in cellular processes through phosphorylation of substrates, which could potentially involve non-canonical targets due to its atypical nature. Activators targeting ADCK1 would aim to enhance its kinase activity, potentially by promoting its phosphorylation activity, stabilizing its active conformation, or facilitating its interaction with substrates or regulatory proteins.
The discovery and optimization of ADCK1 activators would likely involve a combination of in silico modeling and empirical screening approaches. Molecular modeling could provide insights into the three-dimensional structure of ADCK1, revealing potential binding sites for activators and informing the design of molecules that could fit into these sites. These in silico predictions would be complemented with high-throughput screening campaigns to empirically test libraries of small molecules for their ability to increase the kinase activity of ADCK1. Such screenings might involve using recombinant ADCK1 in enzymatic assays that can detect phosphorylation events, or they might employ cell-based assays wherein the downstream effects of ADCK1 activation can be monitored.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin directly activates adenylate cyclase, increasing cAMP levels in cells. The rise in cAMP can enhance protein kinase A (PKA) activity, which could phosphorylate and thereby increase ADCK1 activity as part of its regulation in cellular signaling. | ||||||
A-769662 | 844499-71-4 | sc-203790 sc-203790A sc-203790B sc-203790C sc-203790D | 10 mg 50 mg 100 mg 500 mg 1 g | $184.00 $741.00 $1076.00 $3417.00 $5304.00 | 23 | |
A-769662 is an activator of AMP-activated protein kinase (AMPK). As AMPK can influence various downstream targets involved in cellular energy homeostasis, the activation of AMPK could enhance ADCK1 activity by affecting its phosphorylation state in response to cellular energy levels. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium concentration, which can activate calcium/calmodulin-dependent protein kinases. These kinases can then increase ADCK1 activity through phosphorylation or by affecting its interaction with other cellular proteins. | ||||||
Calcium dibutyryladenosine cyclophosphate | 362-74-3 | sc-482205 | 25 mg | $147.00 | ||
Dibutyryl-cAMP, a cAMP analog, can permeate cell membranes and mimic the action of endogenous cAMP, thereby activating PKA. PKA activation can lead to the phosphorylation and enhancement of ADCK1 activity within its signaling pathways. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Phorbol 12-myristate 13-acetate (PMA) is a diacylglycerol analog that activates protein kinase C (PKC). PKC activation can result in the phosphorylation of ADCK1, potentially increasing its activity in response to second messenger signaling. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol is known to activate sirtuins, particularly SIRT1, which can deacetylate proteins and affect their function. The activation of SIRT1 could lead to the deacetylation of ADCK1, potentially enhancing its activity through changes in protein stability or interactions. | ||||||
8-Bromoadenosine 3′,5′-cyclic monophosphate | 23583-48-4 | sc-217493B sc-217493 sc-217493A sc-217493C sc-217493D | 25 mg 50 mg 100 mg 250 mg 500 mg | $108.00 $169.00 $295.00 $561.00 $835.00 | 2 | |
8-Bromoadenosine 3',5'-cyclic monophosphate (8-Br-cAMP) is a stable cAMP analog that activates PKA. Through PKA activation, this compound could enhance ADCK1 activity by phosphorylation and regulation within cAMP-dependent pathways. | ||||||
ZM 241385 | 139180-30-6 | sc-361421 sc-361421A | 5 mg 25 mg | $92.00 $356.00 | 1 | |
ZM-241385 acts as an antagonist at the A2A adenosine receptor, potentially leading to increased activity of adenylate cyclase and subsequent cAMP accumulation. The rise in cAMP could activate PKA, which in turn could phosphorylate ADCK1, enhancing its activity. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium chloride can inhibit GSK-3, which may lead to the stabilization and activation of various proteins. Inhibition of GSK-3 could lead to a change in ADCK1 activity by altering the phosphorylation balance that controls ADCK1's function. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin has been shown to activate AMPK, which could influence various metabolic pathways and potentially enhance ADCK1 activity through alterations in cellular energy balance and by promoting the phosphorylation of ADCK1. | ||||||